Italian intersociety consensus on DOAC use in internal medicine.
about
Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes.Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations.Is it reasonable to use a lower DOAC dose in some patients with VTE? NO.The involvement of pharmacies in the screening of undiagnosed atrial fibrillation.Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents.
P2860
Italian intersociety consensus on DOAC use in internal medicine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Italian intersociety consensus on DOAC use in internal medicine.
@en
Italian intersociety consensus on DOAC use in internal medicine.
@nl
type
label
Italian intersociety consensus on DOAC use in internal medicine.
@en
Italian intersociety consensus on DOAC use in internal medicine.
@nl
prefLabel
Italian intersociety consensus on DOAC use in internal medicine.
@en
Italian intersociety consensus on DOAC use in internal medicine.
@nl
P2093
P2860
P50
P1476
Italian intersociety consensus on DOAC use in internal medicine.
@en
P2093
Antonella Tufano
Armando D'Angelo
Cecilia Becattini
Domenico Prisco
FADOI (Federation of Associations of Hospital Doctors on Internal Medicine)
Francesca Santilli
Francesco Dentali
Giovanni Davì
Giovanni Di Minno
Gualberto Gussoni
P2860
P2888
P304
P356
10.1007/S11739-017-1628-6
P577
2017-02-13T00:00:00Z